415 related articles for article (PubMed ID: 26492813)
1. Implications of co-infection of Leptomonas in visceral leishmaniasis in India.
Selvapandiyan A; Ahuja K; Puri N; Krishnan A
Parasitology; 2015 Dec; 142(14):1657-62. PubMed ID: 26492813
[TBL] [Abstract][Full Text] [Related]
2. Selective elimination of Leptomonas from the in vitro co-culture with Leishmania.
Ahuja K; Arora G; Khare P; Selvapandiyan A
Parasitol Int; 2015 Aug; 64(4):1-5. PubMed ID: 25582929
[TBL] [Abstract][Full Text] [Related]
3. SOLiD™ sequencing of genomes of clinical isolates of Leishmania donovani from India confirm leptomonas co-infection and raise some key questions.
Singh N; Chikara S; Sundar S
PLoS One; 2013; 8(2):e55738. PubMed ID: 23418454
[TBL] [Abstract][Full Text] [Related]
4. Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis.
Ghosh S; Banerjee P; Sarkar A; Datta S; Chatterjee M
J Clin Microbiol; 2012 Aug; 50(8):2774-8. PubMed ID: 22622439
[TBL] [Abstract][Full Text] [Related]
5. High resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis.
Ahuja K; Vats A; Beg MA; Kariyawasam KKGDUL; Chaudhury A; Chatterjee M; Karunaweera ND; Selvapandiyan A
Parasitol Int; 2020 Apr; 75():102047. PubMed ID: 31887394
[TBL] [Abstract][Full Text] [Related]
6.
Thakur L; Kushwaha HR; Negi A; Jain A; Jain M
Front Cell Infect Microbiol; 2020; 10():345. PubMed ID: 32760679
[TBL] [Abstract][Full Text] [Related]
7. Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India.
Srivastava P; Prajapati VK; Vanaerschot M; Van der Auwera G; Dujardin JC; Sundar S
Infect Genet Evol; 2010 Oct; 10(7):1145-50. PubMed ID: 20633704
[TBL] [Abstract][Full Text] [Related]
8. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
9. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
[TBL] [Abstract][Full Text] [Related]
10. Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased
Cloots K; Marino P; Burza S; Gill N; Boelaert M; Hasker E
Front Cell Infect Microbiol; 2021; 11():604117. PubMed ID: 33777831
[TBL] [Abstract][Full Text] [Related]
11. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
12. Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from India.
Sukla S; Roy S; Sundar S; Biswas S
Arch Virol; 2017 Dec; 162(12):3827-3835. PubMed ID: 28939968
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis.
Salotra P; Duncan RC; Singh R; Subba Raju BV; Sreenivas G; Nakhasi HL
Microbes Infect; 2006 Mar; 8(3):637-44. PubMed ID: 16469521
[TBL] [Abstract][Full Text] [Related]
14. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
15. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
Dey A; Singh S
Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
[TBL] [Abstract][Full Text] [Related]
17. Differential Metabolic Pathway Analysis of the Proteomes of Leishmania donovani and Leptomonas seymouri.
Singh N; Goel R; Jain E
Proteomics Clin Appl; 2018 Sep; 12(5):e1600087. PubMed ID: 29469990
[TBL] [Abstract][Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
Zijlstra EE; Alves F; Rijal S; Arana B; Alvar J
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005877. PubMed ID: 29145397
[TBL] [Abstract][Full Text] [Related]
19. Detection of Leptomonas seymouri narna-like virus in serum samples of visceral leishmaniasis patients and its possible role in disease pathogenesis.
Sukla S; Nath H; Kamran M; Ejazi SA; Ali N; Das P; Ravichandiran V; Roy S; Biswas S
Sci Rep; 2022 Aug; 12(1):14436. PubMed ID: 36002553
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
